Enhanced anabolic cytokine production and delivery system
AssigneeArthrex, Inc.
InventorsChristopher M. Bare, Brandon L. Roller, Melissa S. Tucker
Life of this patent
Estimating the term…
Loading patent…
AssigneeArthrex, Inc.
InventorsChristopher M. Bare, Brandon L. Roller, Melissa S. Tucker
Estimating the term…
Techniques and devices for removing (filtering out) unwanted/inhibitory components (for example, products, byproducts and/or cell output such as inhibitory catabolic proteins) from a composition (for example, autologous fluid or serum) containing such unwanted/inhibitory components. The devices include at least one construct designed to contain a composition (for example, autologous fluid or serum) containing inhibitory/unwanted components (products, byproducts and/or output of cells such as inhibitory catabolic proteins). The construct is provided with interior walls including specific protein capturing means designed to remove the inhibitory/unwanted component(s) (for example, specific protein(s)) from the composition. Proteins targeted for capture include, but are not limited to, catabolic cytokines such as IL-1β, IL-α, IL-6, TNFα, IFNγ and MMPS as these proteins inhibit the healing process.
A method for selectively removing unwanted components from serum or autologous fluid, comprising:
A method for selectively removing unwanted components from a composition, comprising:
A catabolic cytokines removal system, comprising:
Dependencies are inferred from the claim text.